Aerosol is suspension of liquid or solid particles in a carrier gas, which makes use of it for treatment of respiratory system related diseases. Different forms of drugs can be utilized for aerosol therapy such as solid particles, liquid particles, solutions, and suspensions. Until recently, aerosol therapy concentrated primarily on treatment of asthma and COPD for which, pressurized metered-dose inhaler device was used. However, the role of aerosol therapy is expanding beyond the initial focus. This expansion eliminated CFC-based traditional metered-dose inhalers devices. This will ultimately boost the market growth of aerosol therapy in the field of gene therapy, inhalation therapy and vaccination. Aerosol therapy is a natural and easiest way to treat asthma, COPD, cystic fibrosis, and broncho pulmonary dysplasia (BPD). Aerosol therapy is also used to deliver insulin, vaccines of influenza and measles, and pain medications. Aerosol treatment therapy gives an excellent and cost-efficient drug delivery. This therapy is effective for patients who cannot use metered-dose inhalers; primary inhalation devices are produced that guarantee breath-actuated aerosol delivery with minimal side effects.
Currently metered dose inhaler majorly contributes to the market and is expected to dominate the market over the forecast period. As per the data, COPD is third leading cause of death and fifth leading cause of disability. Also, factors like increasing pollution, improper lifestyles are the factors that drive the growth of the market.
Market Analysis and Insights: Global Aerosol Therapy Market
The global Aerosol Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Aerosol Therapy Scope and Market Size
Aerosol Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Aerosol Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Merck
Boehringer Ingelheim
GlaxoSmithKline
AstraZeneca
Novartis
Teva Pharmaceuticals
Opko Health
Omron Healthcare
Medtronic
GE Healthcare
Philips Healthcare
Agilent Technologies
GF Health Products
Aerosol Therapy Breakdown Data by Type
Inhalers
Nebulizers
Bronchodilators
Aerosol Therapy Breakdown Data by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Individual
Currently metered dose inhaler majorly contributes to the market and is expected to dominate the market over the forecast period. As per the data, COPD is third leading cause of death and fifth leading cause of disability. Also, factors like increasing pollution, improper lifestyles are the factors that drive the growth of the market.
Market Analysis and Insights: Global Aerosol Therapy Market
The global Aerosol Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Aerosol Therapy Scope and Market Size
Aerosol Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Aerosol Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Merck
Boehringer Ingelheim
GlaxoSmithKline
AstraZeneca
Novartis
Teva Pharmaceuticals
Opko Health
Omron Healthcare
Medtronic
GE Healthcare
Philips Healthcare
Agilent Technologies
GF Health Products
Aerosol Therapy Breakdown Data by Type
Inhalers
Nebulizers
Bronchodilators
Aerosol Therapy Breakdown Data by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Individual
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Aerosol Therapy Revenue
1.4 Market by Type
1.4.1 Global Aerosol Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Inhalers
1.4.3 Nebulizers
1.4.4 Bronchodilators
1.5 Market by Application
1.5.1 Global Aerosol Therapy Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.5.5 Individual
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Aerosol Therapy Market Perspective (2015-2026)
2.2 Global Aerosol Therapy Growth Trends by Regions
2.2.1 Aerosol Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Aerosol Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Aerosol Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Aerosol Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Aerosol Therapy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Aerosol Therapy Players by Market Size
3.1.1 Global Top Aerosol Therapy Players by Revenue (2015-2020)
3.1.2 Global Aerosol Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Aerosol Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Aerosol Therapy Market Concentration Ratio
3.2.1 Global Aerosol Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Aerosol Therapy Revenue in 2019
3.3 Aerosol Therapy Key Players Head office and Area Served
3.4 Key Players Aerosol Therapy Product Solution and Service
3.5 Date of Enter into Aerosol Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Aerosol Therapy Historic Market Size by Type (2015-2020)
4.2 Global Aerosol Therapy Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Aerosol Therapy Market Size by Application (2015-2020)
5.2 Global Aerosol Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Aerosol Therapy Market Size (2015-2020)
6.2 Aerosol Therapy Key Players in North America (2019-2020)
6.3 North America Aerosol Therapy Market Size by Type (2015-2020)
6.4 North America Aerosol Therapy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Aerosol Therapy Market Size (2015-2020)
7.2 Aerosol Therapy Key Players in Europe (2019-2020)
7.3 Europe Aerosol Therapy Market Size by Type (2015-2020)
7.4 Europe Aerosol Therapy Market Size by Application (2015-2020)
8 China
8.1 China Aerosol Therapy Market Size (2015-2020)
8.2 Aerosol Therapy Key Players in China (2019-2020)
8.3 China Aerosol Therapy Market Size by Type (2015-2020)
8.4 China Aerosol Therapy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Aerosol Therapy Market Size (2015-2020)
9.2 Aerosol Therapy Key Players in Japan (2019-2020)
9.3 Japan Aerosol Therapy Market Size by Type (2015-2020)
9.4 Japan Aerosol Therapy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Aerosol Therapy Market Size (2015-2020)
10.2 Aerosol Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Aerosol Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Aerosol Therapy Market Size by Application (2015-2020)
11 India
11.1 India Aerosol Therapy Market Size (2015-2020)
11.2 Aerosol Therapy Key Players in India (2019-2020)
11.3 India Aerosol Therapy Market Size by Type (2015-2020)
11.4 India Aerosol Therapy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Aerosol Therapy Market Size (2015-2020)
12.2 Aerosol Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Aerosol Therapy Market Size by Type (2015-2020)
12.4 Central & South America Aerosol Therapy Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Merck
13.1.1 Merck Company Details
13.1.2 Merck Business Overview
13.1.3 Merck Aerosol Therapy Introduction
13.1.4 Merck Revenue in Aerosol Therapy Business (2015-2020))
13.1.5 Merck Recent Development
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Details
13.2.2 Boehringer Ingelheim Business Overview
13.2.3 Boehringer Ingelheim Aerosol Therapy Introduction
13.2.4 Boehringer Ingelheim Revenue in Aerosol Therapy Business (2015-2020)
13.2.5 Boehringer Ingelheim Recent Development
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Details
13.3.2 GlaxoSmithKline Business Overview
13.3.3 GlaxoSmithKline Aerosol Therapy Introduction
13.3.4 GlaxoSmithKline Revenue in Aerosol Therapy Business (2015-2020)
13.3.5 GlaxoSmithKline Recent Development
13.4 AstraZeneca
13.4.1 AstraZeneca Company Details
13.4.2 AstraZeneca Business Overview
13.4.3 AstraZeneca Aerosol Therapy Introduction
13.4.4 AstraZeneca Revenue in Aerosol Therapy Business (2015-2020)
13.4.5 AstraZeneca Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview
13.5.3 Novartis Aerosol Therapy Introduction
13.5.4 Novartis Revenue in Aerosol Therapy Business (2015-2020)
13.5.5 Novartis Recent Development
13.6 Teva Pharmaceuticals
13.6.1 Teva Pharmaceuticals Company Details
13.6.2 Teva Pharmaceuticals Business Overview
13.6.3 Teva Pharmaceuticals Aerosol Therapy Introduction
13.6.4 Teva Pharmaceuticals Revenue in Aerosol Therapy Business (2015-2020)
13.6.5 Teva Pharmaceuticals Recent Development
13.7 Opko Health
13.7.1 Opko Health Company Details
13.7.2 Opko Health Business Overview
13.7.3 Opko Health Aerosol Therapy Introduction
13.7.4 Opko Health Revenue in Aerosol Therapy Business (2015-2020)
13.7.5 Opko Health Recent Development
13.8 Omron Healthcare
13.8.1 Omron Healthcare Company Details
13.8.2 Omron Healthcare Business Overview
13.8.3 Omron Healthcare Aerosol Therapy Introduction
13.8.4 Omron Healthcare Revenue in Aerosol Therapy Business (2015-2020)
13.8.5 Omron Healthcare Recent Development
13.9 Medtronic
13.9.1 Medtronic Company Details
13.9.2 Medtronic Business Overview
13.9.3 Medtronic Aerosol Therapy Introduction
13.9.4 Medtronic Revenue in Aerosol Therapy Business (2015-2020)
13.9.5 Medtronic Recent Development
13.10 GE Healthcare
13.10.1 GE Healthcare Company Details
13.10.2 GE Healthcare Business Overview
13.10.3 GE Healthcare Aerosol Therapy Introduction
13.10.4 GE Healthcare Revenue in Aerosol Therapy Business (2015-2020)
13.10.5 GE Healthcare Recent Development
13.11 Philips Healthcare
10.11.1 Philips Healthcare Company Details
10.11.2 Philips Healthcare Business Overview
10.11.3 Philips Healthcare Aerosol Therapy Introduction
10.11.4 Philips Healthcare Revenue in Aerosol Therapy Business (2015-2020)
10.11.5 Philips Healthcare Recent Development
13.12 Agilent Technologies
10.12.1 Agilent Technologies Company Details
10.12.2 Agilent Technologies Business Overview
10.12.3 Agilent Technologies Aerosol Therapy Introduction
10.12.4 Agilent Technologies Revenue in Aerosol Therapy Business (2015-2020)
10.12.5 Agilent Technologies Recent Development
13.13 GF Health Products
10.13.1 GF Health Products Company Details
10.13.2 GF Health Products Business Overview
10.13.3 GF Health Products Aerosol Therapy Introduction
10.13.4 GF Health Products Revenue in Aerosol Therapy Business (2015-2020)
10.13.5 GF Health Products Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Aerosol Therapy Revenue
1.4 Market by Type
1.4.1 Global Aerosol Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Inhalers
1.4.3 Nebulizers
1.4.4 Bronchodilators
1.5 Market by Application
1.5.1 Global Aerosol Therapy Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.5.5 Individual
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Aerosol Therapy Market Perspective (2015-2026)
2.2 Global Aerosol Therapy Growth Trends by Regions
2.2.1 Aerosol Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Aerosol Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Aerosol Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Aerosol Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Aerosol Therapy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Aerosol Therapy Players by Market Size
3.1.1 Global Top Aerosol Therapy Players by Revenue (2015-2020)
3.1.2 Global Aerosol Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Aerosol Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Aerosol Therapy Market Concentration Ratio
3.2.1 Global Aerosol Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Aerosol Therapy Revenue in 2019
3.3 Aerosol Therapy Key Players Head office and Area Served
3.4 Key Players Aerosol Therapy Product Solution and Service
3.5 Date of Enter into Aerosol Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Aerosol Therapy Historic Market Size by Type (2015-2020)
4.2 Global Aerosol Therapy Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Aerosol Therapy Market Size by Application (2015-2020)
5.2 Global Aerosol Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Aerosol Therapy Market Size (2015-2020)
6.2 Aerosol Therapy Key Players in North America (2019-2020)
6.3 North America Aerosol Therapy Market Size by Type (2015-2020)
6.4 North America Aerosol Therapy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Aerosol Therapy Market Size (2015-2020)
7.2 Aerosol Therapy Key Players in Europe (2019-2020)
7.3 Europe Aerosol Therapy Market Size by Type (2015-2020)
7.4 Europe Aerosol Therapy Market Size by Application (2015-2020)
8 China
8.1 China Aerosol Therapy Market Size (2015-2020)
8.2 Aerosol Therapy Key Players in China (2019-2020)
8.3 China Aerosol Therapy Market Size by Type (2015-2020)
8.4 China Aerosol Therapy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Aerosol Therapy Market Size (2015-2020)
9.2 Aerosol Therapy Key Players in Japan (2019-2020)
9.3 Japan Aerosol Therapy Market Size by Type (2015-2020)
9.4 Japan Aerosol Therapy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Aerosol Therapy Market Size (2015-2020)
10.2 Aerosol Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Aerosol Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Aerosol Therapy Market Size by Application (2015-2020)
11 India
11.1 India Aerosol Therapy Market Size (2015-2020)
11.2 Aerosol Therapy Key Players in India (2019-2020)
11.3 India Aerosol Therapy Market Size by Type (2015-2020)
11.4 India Aerosol Therapy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Aerosol Therapy Market Size (2015-2020)
12.2 Aerosol Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Aerosol Therapy Market Size by Type (2015-2020)
12.4 Central & South America Aerosol Therapy Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Merck
13.1.1 Merck Company Details
13.1.2 Merck Business Overview
13.1.3 Merck Aerosol Therapy Introduction
13.1.4 Merck Revenue in Aerosol Therapy Business (2015-2020))
13.1.5 Merck Recent Development
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Details
13.2.2 Boehringer Ingelheim Business Overview
13.2.3 Boehringer Ingelheim Aerosol Therapy Introduction
13.2.4 Boehringer Ingelheim Revenue in Aerosol Therapy Business (2015-2020)
13.2.5 Boehringer Ingelheim Recent Development
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Details
13.3.2 GlaxoSmithKline Business Overview
13.3.3 GlaxoSmithKline Aerosol Therapy Introduction
13.3.4 GlaxoSmithKline Revenue in Aerosol Therapy Business (2015-2020)
13.3.5 GlaxoSmithKline Recent Development
13.4 AstraZeneca
13.4.1 AstraZeneca Company Details
13.4.2 AstraZeneca Business Overview
13.4.3 AstraZeneca Aerosol Therapy Introduction
13.4.4 AstraZeneca Revenue in Aerosol Therapy Business (2015-2020)
13.4.5 AstraZeneca Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview
13.5.3 Novartis Aerosol Therapy Introduction
13.5.4 Novartis Revenue in Aerosol Therapy Business (2015-2020)
13.5.5 Novartis Recent Development
13.6 Teva Pharmaceuticals
13.6.1 Teva Pharmaceuticals Company Details
13.6.2 Teva Pharmaceuticals Business Overview
13.6.3 Teva Pharmaceuticals Aerosol Therapy Introduction
13.6.4 Teva Pharmaceuticals Revenue in Aerosol Therapy Business (2015-2020)
13.6.5 Teva Pharmaceuticals Recent Development
13.7 Opko Health
13.7.1 Opko Health Company Details
13.7.2 Opko Health Business Overview
13.7.3 Opko Health Aerosol Therapy Introduction
13.7.4 Opko Health Revenue in Aerosol Therapy Business (2015-2020)
13.7.5 Opko Health Recent Development
13.8 Omron Healthcare
13.8.1 Omron Healthcare Company Details
13.8.2 Omron Healthcare Business Overview
13.8.3 Omron Healthcare Aerosol Therapy Introduction
13.8.4 Omron Healthcare Revenue in Aerosol Therapy Business (2015-2020)
13.8.5 Omron Healthcare Recent Development
13.9 Medtronic
13.9.1 Medtronic Company Details
13.9.2 Medtronic Business Overview
13.9.3 Medtronic Aerosol Therapy Introduction
13.9.4 Medtronic Revenue in Aerosol Therapy Business (2015-2020)
13.9.5 Medtronic Recent Development
13.10 GE Healthcare
13.10.1 GE Healthcare Company Details
13.10.2 GE Healthcare Business Overview
13.10.3 GE Healthcare Aerosol Therapy Introduction
13.10.4 GE Healthcare Revenue in Aerosol Therapy Business (2015-2020)
13.10.5 GE Healthcare Recent Development
13.11 Philips Healthcare
10.11.1 Philips Healthcare Company Details
10.11.2 Philips Healthcare Business Overview
10.11.3 Philips Healthcare Aerosol Therapy Introduction
10.11.4 Philips Healthcare Revenue in Aerosol Therapy Business (2015-2020)
10.11.5 Philips Healthcare Recent Development
13.12 Agilent Technologies
10.12.1 Agilent Technologies Company Details
10.12.2 Agilent Technologies Business Overview
10.12.3 Agilent Technologies Aerosol Therapy Introduction
10.12.4 Agilent Technologies Revenue in Aerosol Therapy Business (2015-2020)
10.12.5 Agilent Technologies Recent Development
13.13 GF Health Products
10.13.1 GF Health Products Company Details
10.13.2 GF Health Products Business Overview
10.13.3 GF Health Products Aerosol Therapy Introduction
10.13.4 GF Health Products Revenue in Aerosol Therapy Business (2015-2020)
10.13.5 GF Health Products Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
